Breakthrough in Leukemia Treatment: Base-Edited CAR T-Cells Achieve Remission In a landmark advancement for cancer therapy, researchers have demonstrated the effectiveness of base-edited CAR T-cells in treating patients with T cell acute lymphoblastic leukemia (T-ALL). This innovative approach not only eliminates cancerous cells but also safeguards the modified T-cells themselves, paving the way for successful … Read more
IGC Pharma Expands Alzheimer’s Disease Trial with New York Clinical Site In a significant step forward for Alzheimer’s disease research, IGC Pharma has broadened the scope of its Phase II CALMA clinical trial. The expansion includes the addition of Integrative Clinical Trials, a Brooklyn, New York-based research facility, as a new site dedicated to evaluating … Read more
Axsome Initiates Pivotal Trial of AXS-14 for Fibromyalgia, Offering New Hope for Millions In a significant development for individuals battling fibromyalgia, Axsome Therapeutics has commenced the FORWARD Phase III clinical trial evaluating the potential of AXS-14 as a novel treatment option. The first patient has now been dosed, marking a crucial step forward in the … Read more